Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ASH21

Recent news which mentions ASH21

BeyondSpring's New Plinabulin Data Shows Fast Onset In Preventing Chemo-Induced Neutropenia
Tickers BYSI
Tags Biotech Health Care BYSI
From Benzinga
Global Blood Raises $300M Via Convertible Debt Offering
Tickers GBT
Tags General Movers Sickle Cell Disease
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Biotech Health Care Market News
From Benzinga
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
Tickers SNY
Tags Hemophilia A Hemophilia General
From Benzinga
Agios Presents Mitapivat Long-Term Data On Hemoglobin Response, Transfusion Burden
Tickers AGIO
Tags Health Care General Biotech
From Benzinga
Precigen Reveals Early Data From CAR-T Candidate In Blood Cancer Patients
Tickers PGEN
Tags Health Care PGEN Phase 1 Trial
From Benzinga
Atara Bio Unveils Pivotal Data On T Cell Therapy Tabelecleucel In Transplant Patients
Tickers ATRA
Tags General Movers Briefs
From Benzinga
Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
Tickers APTO
Tags acute myeloid leukemia General ASH21
From Benzinga
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
Tickers FATE
Tags ASH21 News Briefs
From Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
Tickers GILD
Tags Benzinga lymphoma Phase 2 Trial
From Benzinga
Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial
Tickers SNDX
Tags General SNDX ASH21
From Benzinga
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
Tickers ALXO
Tags Phase 2 Trial Market News Benzinga
From Benzinga
Why Did X4 Pharmaceuticals Shares Crater To 52-Week Low?
Tickers XFOR
Tags General Movers ASH21
From Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
Tickers VIRX
Tags lymphoma Movers Briefs
From Benzinga
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
Tickers BMY JNJ SNY TAK
Tags ASH21 News SNY
From Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
Tickers HARP
Tags HARP multiple myeloma General
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
Tickers JNJ LEGN
Tags Health Care Phase 1 Trial Biotech
From Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
Tickers JAZZ
Tags Phase 3 Trial Health Care General
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags ASH21 Briefs News
From Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Tickers BLUE
Tags Trading Ideas Benzinga Market News
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
Tickers BLUE
Tags Movers Sickle Cell Disease ASH21
From Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
Tickers GILD
Tags Market News GILD Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.